# China NMPA Drug Inspection - Anguo City Juyitang Pharmaceutical Co., Ltd. - Stir-fried chicken gizzard

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/anguo-city-juyitang-pharmaceutical-co-ltd/3d25a8ce-3379-490b-83ee-8f2e3ac26725/
Source feed: China

> China NMPA drug inspection for Anguo City Juyitang Pharmaceutical Co., Ltd. published January 04, 2018. Drug: Stir-fried chicken gizzard. A regulatory announcement from the Beijing Municipal Drug Administration detailed the outcomes of supervision and sampli

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Beijing Municipal Drug Quality and Safety Bulletin, September-December 2017
- Company Name: Anguo City Juyitang Pharmaceutical Co., Ltd.
- Publication Date: 2018-01-04
- Drug Name: Stir-fried chicken gizzard
- Inspection Finding: Properties
- Action Taken: The matter will be investigated and dealt with in accordance with the "Drug Administration Law of the People's Republic of China" and other relevant regulations, and follow-up sampling and testing will be conducted within this jurisdiction as appropriate.
- Summary: A regulatory announcement from the Beijing Municipal Drug Administration detailed the outcomes of supervision and sampling inspections conducted between September and December 2017. These inspections, part of the "2017 Beijing Municipal Food and Drug Safety Monitoring Plan," aimed to assess drug quality across production, operation, and usage within the city. Out of 1602 drug batches sampled, three were found to be non-compliant, resulting in an overall pass rate of 99.81%. Specific companies and their products were cited for quality issues. Beijing Meikangtang Pharmaceutical Technology Co., Ltd.'s "Ligustrum lucidum (Wine Privet Fruit)" failed due to excessive moisture. "Stir-fried Chicken Gizzard," supplied by Beijing Yuyuantang Hospital Management Co., Ltd. and manufactured by Anguo Juyitang Pharmaceutical Co., Ltd., exhibited non-compliant properties. Additionally, Beijing Haiderun Pharmaceutical Group Co., Ltd.'s "Hydrogen Peroxide Solution" was found to have an incorrect quantity. All non-compliances were identified against the standards set in the Chinese Pharmacopoeia 2015 Edition. In response to these findings, the regulatory authority stated its commitment to investigate and address the unqualified drugs. Actions will be taken in accordance with the "Drug Administration Law of the People's Republic of China" and other pertinent regulations. Furthermore, follow-up sampling inspections are planned to ensure continued compliance within the jurisdiction. The announcement underscores the administration's ongoing efforts to maintain public health and safety through rigorous drug quality oversight.

Company: https://www.globalkeysolutions.net/companies/anguo-city-juyitang-pharmaceutical-co-ltd/9c225975-1a1b-434f-b5b2-785df931719e/